...) at entry. Overlap weights balanced biasing factors, including age, sex at birth, atherosclerotic cardiovascular disease risk, CD4 count, estimated glomerular filtration rate, and anchor antiretroviral therapy. Associations between entry NRTI and MACEs were estimated using a marginal Cox proportional...

...) is well documented. However, recent reports suggest that the observed weight gain among persons who switch to INSTIs may be associated with their preswitch regimen. Methods We conducted retrospective analyses of persons with HIV on antiretroviral therapy who switched to a second-generation INSTI...

..., necessitating careful consideration of autonomy, access and equity, stigma, discrimination, sustainability and treatment adherence. cabotegravir ethics HIV injectable antiretroviral therapy rilpivirine sub-Saharan Africa National Institutes of Health 10.13039/100000002 P30A1027763 BO-1122 BO-0423...

... highly prevalent, with more than 90% of children exposed in utero to HIV residing in these regions [ 16 ]. Globally, more than 81% of women living with HIV receive antiretroviral therapy (ART) during their pregnancy. However, their HIV-exposed uninfected (HEU) infants show immunological alterations...

..., follow-up sAb⁺ Abbreviations: ART, antiretroviral therapy; cAb, core antibody; CAB/RPV, cabotegravir/rilpivirine; HBV, hepatitis B virus; sAb, surface antibody; sAg, surface antigen; vax, vaccination. ^aClassification at long-acting injectable ART initiation. Only...

...:https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) African women bone health HIV lactation tenofovir-based antiretroviral therapy (ART) menopause In this issue of JBMR, Ó Breasail et al. ¹ report substantial bone deficits in the peripheral skeleton among 40-60 yr old Zimbabwean women...

... injectable antiretroviral therapy (LAI-ART) is expected to improve health outcomes among persons with HIV. Yet, uptake has been slow and data on potential barriers to access are sparse. We used medication formulary data from state Medicaid and AIDS Drug Assistance Programs (ADAPs) to examine state-level...

... predictors of clinical outcomes among people with human immunodeficiency virus (HIV) starting antiretroviral therapy (ART) in the modern era of rapid ART initiation. Methods We conducted a secondary analysis of a previously reported open-label randomized controlled trial of 2 rapid treatment initiation...

... in real-world clinical settings. We characterized “early adopters” of injectable ART and PrEP in terms of social determinants of health. antiretroviral therapy HIV implementation long-acting injectable PrEP Long-acting injectable (LAI) antiretrovirals for HIV treatment (ART) and prevention (PrEP...

... Therapy Induction Optimisation; ART, antiretroviral therapy; CFU, colony forming units; CSF, cerebrospinal fluid; 5FC, flucytosine; IQR, interquartile range. ^aThe AMBITION trial included 844 participants, 814 of whom were included in the intention to treat analysis after late exclusions...

... cabotegravir integrase strand trasfer inhibitors drug resistance antiretroviral therapy Abstract Background The long-acting injectable regimen of cabotegravir plus rilpivirine (CAB/RPV) emerged as an alternative to oral standard-of-care integrase strand transfer inhibitor (INSTI)–based regimens...

... antiretroviral therapy in children with HIV. These findings may explain persistent TB risk during early antiretroviral therapy among children with HIV. antiretroviral therapy CD4 T cell HIV immune reconstitution tuberculosis National Institute of Allergy and Infectious Diseases 10.13039/100000060...

... <15 years versus 74% for those aged 15 and above [ 2 ]. HIV antiretroviral therapy long-term outcomes children Cameroon Abstract Evidence on long-term outcomes of children receiving antiretroviral therapy (ART) in low- and middle-income countries (LMICs) is of utmost importance to optimize...

... prominent national and international guidelines to compare recommendations for laboratory monitoring for persons on antiretroviral therapy. The United States Department of Health and Human Services guidelines recommend more frequent CD4 count, viral load, hematologic, renal, and liver tests than other...

... page on our site—for further information please contact [email protected]. Abstract Background Complex antiretroviral therapy (ART) regimens, such as those requiring multiple tablets, several doses per day, or both, can negatively affect quality of life and treatment adherence among...

...) globally, with consequences for their health and clinical outcomes. Previous reviews of the influence of micronutrient supplementation on HIV outcomes were conducted in the pre–highly active antiretroviral therapy (pre-HAART) era or included both HAART-naive and HAART-experienced individuals; thus...

... was met for all covariables. The introduction of combination antiretroviral therapy (ART) in the mid-1990s greatly reduced morbidity and mortality rates associated with human immunodeficiency virus (HIV) type 1 viral infection [ 1 ]. Plasma viral loads become undetectable in most people with HIV (PWH...

... immunodeficiency virus (PLHIV) in Federal Capital Territory (FCT), Nigeria. Methods This was a cross-sectional study among PLHIV attending antiretroviral therapy clinics in FCT, Nigeria. We utilized an interviewer-administered, semi-structured questionnaire to collect data on COVID-19 vaccine uptake. Vaccine...

..., antiretroviral therapy (ART) continues to be the primary mode of managing HIV, transforming it from a formerly lethal disease to a less severe one. Adherence to ART can be impacted by several factors, including poor quality of care. Methods A quantitative cross-sectional study design was used to assess...

... is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Background To compare the effects of first-line antiretroviral therapy (ART) with dolutegravir plus lamivudine (DTG...